/ Committee on Shortening the Time Line for New Cancer Treatments, National Cancer Policy Board
Subsequent Statement of Responsibility
; Institute of Medicine and National Research Council of the National Academies
.PUBLICATION, DISTRIBUTION, ETC
Place of Publication, Distribution, etc.
Washington, D.C.
Name of Publisher, Distributor, etc.
: National Academies Press,
Date of Publication, Distribution, etc.
, c2005.
PHYSICAL DESCRIPTION
Specific Material Designation and Extent of Item
xiv, 42 p. ill. 24 cm.
NOTES PERTAINING TO PUBLICATION, DISTRIBUTION, ETC.
Text of Note
e
INTERNAL BIBLIOGRAPHIES/INDEXES NOTE
Text of Note
ng
Text of Note
Includes bibliographical references (p. 41-42).
Text of Note
Includes bibliographical references (p. 41-42).
CONTENTS NOTE
Text of Note
Childhood cancers: Background -- Agents in use and in testing for children with cancer -- The existing capacity for developing new agents specifically for childhood cancers -- Putting the pieces together -- Delays in testing approved agents in children -- The need to prioritize agents for testing in children with cancer -- Testing and labeling of drugs for pediatric use.
TOPICAL NAME USED AS SUBJECT
Drug approval United States
Cancer in children United States
Neoplasms- drug therapy- Child United States
Antineoplastic Agents- Child United States
Clinical Trials United States
Drug Approval United States
Neoplasms- epidemiology- Child United States
DEWEY DECIMAL CLASSIFICATION
Number
618
.
92
.
994
LIBRARY OF CONGRESS CLASSIFICATION
Class number
RA401
.
5
Book number
.
M35
2005
OTHER CLASS NUMBERS
Class number
QZ
275
Book Number
M235
2005
PERSONAL NAME - SECONDARY RESPONSIBILITY
Adamson, Peter C
National Cancer Policy Board (U.S.).Committee on Shortening the Time Line for New Cancer Treatments